Penka Kovacheva specializes in litigation and regulatory investigations within the life sciences and healthcare industries. In addition to being a testifying expert herself, Dr. Kovacheva works closely with academic experts and attorneys, and leads large teams in performing complex economic and statistical analyses on a range of issues within these industries.
In particular, Dr. Kovacheva has extensive experience in:
Antitrust litigation and merger investigations
- Investigated allegations of anticompetitive delay of generic entry, including allegations of reverse payments and product hopping
- Analyzed allegations of price fixing among generic drug manufacturers
- Examined class certification issues in end-payor and direct purchaser class actions
- Estimated competitive effects of a vertical merger between a health insurer and a pharmacy benefit manager
Product misrepresentation and product liability matters
- Assessed the impact of pharmaceutical marketing on prescribers’ behavior and prescription drug sales
- Analyzed pharmaceutical companies’ drug development decisions
Statistical sampling matters
- Performed statistical sampling and evaluated sample designs and extrapolation methods to address allegations of Medicare and Medicaid overpayment for healthcare services
- Assessed the use of sampling to establish liability and damages in False Claims Act matters and government audits of healthcare providers
Intellectual property disputes
- Analyzed indicators of commercial success and nexus to patent claims in Hatch-Waxman disputes
- Assessed potential irreparable harm in the context of preliminary injunction motions
|
|
